Your session is about to expire
← Back to Search
Online PrEP Navigation for HIV Prevention (P2P Trial)
N/A
Waitlist Available
Led By Michele D Kipke, PhD
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
P2P Trial Summary
This trial will develop and test a PrEP activation, navigation and support intervention for young men who have sex with men (YMSM); this population not only has the highest annual incidence of HIV, but also is the least likely to have ever used PrEP.
Who is the study for?
This trial is for young men who have sex with men, and young transgender and non-binary individuals aged 16-26 in the Los Angeles area. They must be HIV negative, not on PrEP or enrolled in another HIV prevention study, identify as a specific race/ethnicity, and have access to an iOS/Android smartphone or tablet.Check my eligibility
What is being tested?
The trial tests 'PrEPresent,' a mobile health platform designed to facilitate access to PrEP for HIV prevention. It includes features like scheduling with navigators and goal setting. Participants will also complete assessments and sessions addressing barriers to accessing PrEP.See study design
What are the potential side effects?
Since this intervention involves using a mobile health platform rather than medication, traditional side effects are not applicable. However, participants may experience stress or anxiety related to discussing personal health issues.
P2P Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Formative Research - PrEP Provider and Navigator Interviews
Formative Research - Youth Working Groups
Patient Navigation Acceptability
+3 moreP2P Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Access to mobile health platform for resources and information about PrEP plus sessions with peer health support navigator, social app interactions, goal setting capabilities
Group II: ControlActive Control1 Intervention
Access to mobile health platform for resources and information about PrEP
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PrEPresent
2021
N/A
~150
Find a Location
Who is running the clinical trial?
University of North CarolinaOTHER
166 Previous Clinical Trials
1,449,457 Total Patients Enrolled
Children's Hospital Los AngelesLead Sponsor
232 Previous Clinical Trials
5,076,618 Total Patients Enrolled
Florida State UniversityOTHER
198 Previous Clinical Trials
30,536 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not had anal sex or tested positive for a sexually transmitted infection (STI) in the last 6 months.You must identify your race as White/Caucasian, Black/African American, Hispanic/Latino/Latinx, or mixed-race.You do not speak English.You do not identify as White/Caucasian, Black/African American, Hispanic/Latino/Latinx, or mixed-race.You do not identify as gay, bisexual or any other same-sex identity, and/or you have not had sexual contact with someone who has a penis in the last 12 months.You must be between 16 and 26 years of age.You live in the Los Angeles city region.You are a man who has had sexual contact with another man in the past year.You have engaged in anal sex or tested positive for a sexually transmitted infection (STI) in the past 6 months.You are already taking or planning to start PrEP medication within the next week, and/or currently participating in another study for HIV prevention.You can be any gender, including if you identify differently from the gender assigned to you at birth.You are not from a racial or ethnic background that has been identified for this study.You are not male, or you do not identify with the gender assigned to you at birth.You do not identify as gay, bisexual, or another same-sex identity, and you haven't had sex with someone who has a penis in the past year.You identify with one or more of the following racial and ethnic categories: White/Caucasian, Black/African American, Latinx, Asian-Pacific Islander, Indigenous, Native American or mixed-race.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Experimental
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current recruitment size for this experiment?
"Affirmative. According to the listing on clinicaltrials.gov, this experiment is actively welcoming participants. It was first posted on January 28th 2021 and updated most recently on July 21st 2022; 150 patients need to be recruited from a single site location."
Answered by AI
Does this research consider applicants under the age of forty?
"Patients between the ages of 16 and 26 are eligible to enroll in this clinical trial."
Answered by AI
What criteria must a person fulfill in order to take part in this clinical exploration?
"To take part in this research study, participants must have a documented HIV infection and be between 16 to 26 years old. A total of 150 people will ultimately be chosen for the trial."
Answered by AI
Are individuals currently allowed to participate in this experimentation?
"The online database, clinicaltrials.gov, attests to this trials current state of recruitment. It has been open since January 28th 2021 and was last updated on July 21st 2022."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger